Investor FAQs

Lotus builds its Best-in-Class pipeline driven by combined efforts of R&D and BD. With expertise in high‑barrier oncology and complex generics, we focus on addressing unmet medical needs. Through targeted acquisitions and licensing of branded medicines, 505(b)(2) products, biosimilars, and NCEs, we continue to build a differentiated portfolio that bolsters treatment access for patients worldwide.

Lotus has a strong global footprint with more than 90 markets around the world through direct access with self-owned sales network in markets such as Taiwan, South Korea, Thailand, Vietnam, the Philippines etc., as well as partnerships in markets such as North America and Europe.

Lotus's fiscal year ends on December 31.

Considering the Company is in an industry in a growth phase, profits may be distributed in total after taking into consideration financial, business, and operational factors, and to be distributed upon approved by the shareholders' meeting. It is expected that the dividends, subject to the shareholders' approval, are in the range of 10% to 100% of distributable profits of a year, among which cash dividend shall not be less than 10% of total distribution. Dividend payout may be adjusted by the Board of Directors based on changes in the internal and external environment.

In terms of the environment, Lotus' sustainable development goal is to reduce the environmental impact of its overall operations. In addition to the EHS Department, which ensures factory operations comply with environmental regulations, the Engineering Department has implemented an energy management policy aiming to improve energy efficiency, continuously enhancing environmental protection efforts. Lotus has established an EHS Department and formed an Environmental, Health and Safety (EHS) Management Committee, as well as developed an EHS Guidelines Manual to oversee and manage the environmental impact of waste generated by the pharmaceutical manufacturing sites. Since 2021, Lotus has calculated and recorded greenhouse gas emissions, water consumption, and total waste weight at its manufacturing plants and R&D centers in accordance with standards announced by the Bureau of Energy. Furthermore, Lotus completed the 2024 greenhouse gas inventory and assurance for its major operating locations following the Sustainable Development Roadmap issued by the Financial Supervisory Commission.